Most founders picture a fundraise as a sales process: build a great deck, line up meetings, charm investors, negotiate valuation, sign. That is half the picture, and it is the half that gets all the attention. The other half is quieter, less glamorous, and far more likely to decide whether your round closes on time, closes late, closes at a lower price, or quietly dies on the operating table. That other half is readiness—the legal, structural, and record-keeping work that turns your company from a promising idea with messy paperwork into a clean, fundable asset a sophisticated investor can underwrite with confidence.

This article is the readiness playbook, and it occupies a deliberate lane within our startup-finance series. Its sibling, Navigating the Capital Raising Maze, covers what you are selling and the law that governs the sale—the Section 5 registration requirement of the Securities Act, the Regulation D exemptions you rely on instead, accredited-investor rules, and the menu of instruments from priced equity to SAFEs and convertible notes. The Complete Guide to Adding New Investors After Your Seed Round picks up the story after you have outside money on the cap table and need to run a priced round, with all the dilution math and deal terms that entails. SAFEs: An Overview of Simple Agreements for Future Equity drills into the single most common seed instrument, and Popular Legal Documents for Startups is the annotated catalog of the paperwork itself. This piece is the connective tissue: how to get your house in order before a term sheet lands so that diligence is a formality rather than an excavation.

The audience is deliberately broad. A first-time founder should follow every concept without a law degree. A lawyer should find the citations accurate and usable. And a judge reading this years later in a dispute should find that we explained the law honestly. To that end we define each term of art the first time it appears, and we use a running hypothetical—Acme Robotics, Inc., an invented two-founder hardware-plus-software startup that recurs across this series—to make the abstractions concrete. (Acme is a teaching device. Any resemblance to a real company is coincidence.)

A word on what "diligence-ready" means, because it is the organizing idea of everything below. Due diligence is the investigation an investor and its lawyers conduct to verify that your company is what your pitch said it is, that it owns what it claims to own, and that no hidden liabilities lurk beneath the surface. A company is "diligence-ready" when an investor's counsel can open your data room, run the standard checklist, and find clean, complete, internally consistent answers—no surprises, no gaps, no "we'll get back to you on that." Diligence-ready is not a document; it is a state of being. Everything that follows is in service of reaching it.

Why Readiness Is Worth More Than Valuation

Founders fixate on valuation because it is the number that determines how much of the company they keep. That is rational. But valuation is a negotiated outcome that depends heavily on factors you cannot fully control—market conditions, comparable deals, the investor's fund dynamics. Readiness, by contrast, is almost entirely within your control, and it influences the deal in ways that compound.

Consider what an unprepared company actually costs itself. First, time. A messy cap table or a missing founder IP assignment can add weeks or months to a deal while lawyers clean it up—and in fundraising, time kills. Investor enthusiasm has a half-life, market windows close, and a company burning cash cannot afford a three-month detour. Second, price. When diligence surfaces a problem, the investor rarely walks; the investor reprices. A discovered liability becomes a negotiating lever, and the founder—now over a barrel and short on runway—gives ground on valuation, on liquidation preference, on board control. Third, trust. Diligence is the investor's first real look at how you operate. A clean, organized, responsive process signals that you will be a competent steward of their capital; a chaotic one plants a seed of doubt that colors every subsequent negotiation. Fourth, optionality. The same hygiene that makes you fundable makes you acquirable. The cap table, IP chain, and corporate records a Series A investor inspects are the very ones an acquirer's lawyers will tear through years later—the standard private-M&A due-diligence request list runs to seventeen categories beginning with corporate records and the cap table and ending with taxes, and a startup that is ready for one is largely ready for the other. Cleaning them up now pays dividends at every future liquidity event.

The single most important mindset shift is this: start before you need to. The worst time to discover that a former contractor never signed an IP assignment is the week a term sheet arrives. The best time to fix it is eighteen months earlier, when the contractor still likes you and a signature costs nothing. Readiness is cheap when you have time and ruinously expensive when you do not. The rest of this article assumes you are reading it early. If you are not—if a term sheet is already on the table—read it anyway, then triage ruthlessly for the landmines in the final sections.

Entity Formation: Why Venture-Track Startups Choose the Delaware C-Corporation

The first readiness question is the most foundational: is your company the right kind of legal entity, formed in the right place? For a venture-track startup—one that intends to raise institutional equity from venture capital ("VC") funds and angels and eventually pursue an acquisition or initial public offering ("IPO")—the answer is almost always a Delaware C-corporation, and it is worth understanding precisely why, because the reasons explain a great deal about how the venture ecosystem is wired.

C-Corporation Versus LLC: The Tax and Structural Logic

A C-corporation (named for Subchapter C of the Internal Revenue Code) is a corporation taxed as a separate entity: the company pays corporate income tax on its profits, and shareholders pay tax again on dividends or on the gain when they sell. This "double taxation" sounds like a disadvantage, and for a profitable small business distributing cash to its owners, it can be—when a C-corp sells its assets and liquidates, the gain is taxed twice, once at the entity and once at the shareholder, while a partnership-taxed LLC's owners generally face only a single layer. But a venture-backed startup is not that business. It typically loses money for years while it reinvests every dollar into growth, so there are no profits to tax twice, and the eventual exit is usually structured as a stock sale, which is taxed only once at the seller level. The double-taxation concern is largely theoretical for a company on the venture path.

A limited liability company ("LLC"), by contrast, is by default a pass-through entity: it pays no entity-level tax, and its profits and losses flow through to the members, who report them on their personal returns. Pass-through treatment and structural flexibility make the LLC an excellent vehicle for a bootstrapped consulting firm, a real estate holding company, or a family business. It is a poor vehicle for venture fundraising, for several concrete reasons.

First, venture funds frequently cannot or will not invest in LLCs. Many VC funds have limited partners ("LPs")—the institutions and individuals whose money the fund invests—that are tax-exempt entities such as university endowments and pension funds, or foreign investors. A pass-through LLC's income flows through to those LPs, and certain LLC income can generate "unrelated business taxable income" (UBTI) for a tax-exempt LP or effectively-connected income for a foreign LP, creating tax filing obligations and liabilities those investors specifically structured their funds to avoid. A C-corporation, which absorbs tax at the entity level and passes nothing through, neatly sidesteps this. For many funds, "we only invest in C-corps" is not a preference; it is a hard constraint imposed by their own fund documents.

Second, equity compensation is vastly cleaner in a corporation. Startups attract talent by granting stock—the classic recruiting tool for a company that cannot pay market-rate cash salaries. Corporations issue restricted stock and stock options (including the incentive stock options discussed below) as a matter of routine, with decades of settled tax law built around them. LLCs cannot issue conventional stock options; they grant "profits interests" or "unit options," which are workable but unfamiliar, harder to explain to recruits, and accompanied by their own tax complexity. (Profits interests have their own Section 83(b) wrinkle—holders often file a protective election precisely because the interest is designed to have zero value at grant under the Revenue Procedure 93-27 safe harbor, and a failed structuring could otherwise create phantom income.) When you are competing for engineers against companies offering clean option grants, an exotic LLC equity structure is a recruiting handicap.

Third, the Qualified Small Business Stock ("QSBS") exclusion is available only for C-corporation stock. Under Section 1202 of the Internal Revenue Code (26 U.S.C. § 1202), a non-corporate shareholder who acquires QSBS at original issuance and holds it for more than five years may exclude a very substantial portion of the gain on sale from federal income tax, subject to per-issuer caps. QSBS is one of the most valuable tax benefits in the startup ecosystem, and it requires stock in a domestic C-corporation that satisfies the statute's gross-asset and active-business tests. Founders who form an LLC and convert later can lose years of the five-year holding clock, because the clock runs from the date the C-corp stock is issued. (We return to QSBS in the founder-equity section, because the Section 83(b) election ties directly into it.)

Fourth, preferred stock is the native language of venture financing. VC rounds are structured as sales of preferred stock—a class of equity carrying rights senior to the common stock founders and employees hold, such as a liquidation preference (the right to be paid back first in a sale) and protective provisions (veto rights over major decisions). Corporations issue multiple classes and series of stock effortlessly. LLCs can replicate this with a sufficiently elaborate operating agreement, but doing so is bespoke, expensive, and unfamiliar to investors whose term sheets are keyed to corporate preferred stock. The friction is real and avoidable.

For the deeper version of this analysis—when an LLC, an S-corporation, or a holding-company structure actually makes sense, and how operating, holding, and parent entities fit together—see Corporate Structuring and Running Multiple Businesses. And for the document-by-document view of formation, see Popular Legal Documents for Startups.

Why Delaware

Having settled on a C-corporation, the next question is where to incorporate. For venture-track companies, Delaware is the overwhelming default, and again the reasons are specific rather than reflexive.

Delaware's General Corporation Law (the "DGCL," found at Title 8 of the Delaware Code) is the most developed body of corporate statute in the United States, and the Delaware Court of Chancery is a specialized business court—no juries, expert judges, and an enormous corpus of written opinions interpreting nearly every corporate scenario a startup will encounter. This predictability is itself an asset: when a dispute arises over fiduciary duties, board approval of a transaction, or the mechanics of a stock issuance, Delaware law usually supplies a clear answer, and lawyers nationwide know that answer without research. Investors and their counsel are deeply familiar with Delaware, their standard financing documents are drafted against the DGCL, and a Delaware charter is one less thing to negotiate or diligence. Restricted-stock and financing documents routinely invoke specific DGCL provisions—for example, Sections 151(f) and 202(a), which govern the notices a corporation must give stockholders about the rights and restrictions attached to their shares—and venture lawyers handle these as a matter of course. The practical reality is simple: a venture investor expects a Delaware C-corp, and arriving as one removes a point of friction at exactly the moment you cannot afford friction.

If You Are Already an LLC: The Conversion Question

Many founders, sensibly, begin life as an LLC for its simplicity and early-stage tax efficiency, then convert to a Delaware C-corporation as a venture raise approaches. Conversion is a well-worn path, but it is not free, and the method matters. There are generally three routes: (1) a statutory conversion, available where state law permits converting the LLC directly into a corporation, often the cleanest and most tax-efficient option; (2) a merger of the LLC into a newly formed Delaware C-corp; and (3) an asset contribution or "assets-up" transaction, in which a new corporation is formed and the LLC's assets and liabilities are contributed to it in exchange for stock. The federal tax consequences of these alternatives differ in detail—the rules governing how an LLC's assets, liabilities, and members' interests move into a corporation are notoriously fact-specific—and a botched route can trigger gain recognition.

Each route also has different effects on contracts. Before converting, conduct a focused contract review hunting for three things: change-of-control provisions (clauses that give a counterparty rights—often termination—when the company's ownership or structure changes); anti-assignment clauses (which may require the counterparty's consent before a contract can move to the new entity); and termination rights triggered by a fundamental corporate change. Finding such provisions is normal and rarely fatal—usually a short conversation and a consent letter resolves them—but you want to find them on your schedule, not in the middle of diligence. (This is the same exercise an M&A lawyer performs on the buy side, where "Is this contract assignable, and does the deal trigger a change-of-control clause?" is one of the first questions on every checklist.) Because the tax analysis is genuinely complex and the wrong choice can trigger tax or restart the QSBS clock, conversion is one of the few readiness tasks where engaging both corporate and tax counsel early is non-negotiable.

The Cap Table: Clean Equity Hygiene

The capitalization table ("cap table") is the master record of who owns what in your company: every share of common stock, every share of preferred, every option granted, every warrant, every convertible instrument, and the percentage of the company each represents on both an issued and a fully diluted basis. ("Fully diluted" means counting every share that could exist if all options were exercised and all convertibles converted—the number that actually reflects ownership and dilution.) The cap table is the single document a diligence lawyer studies most closely, because it is where ownership lives, and ownership is what the investor is buying. It is no accident that "stockholder information" and "securities issuances" sit at the very top of the standard private-company diligence request list, complete with demands for every option, SAR, warrant, and convertible, with its grant-date fair market value, exercise price, and vesting schedule.

A clean cap table is internally consistent, fully documented, and reconcilable to source documents. For every line on it, there should be a corresponding, signed, board-approved instrument in the corporate records: a stock purchase agreement for each founder's shares, a board consent authorizing each issuance, an option grant agreement for each option, a note or SAFE for each convertible. The cap table is a summary; the underlying paper is the proof. When the two do not match—when the spreadsheet says a founder owns 4,000,000 shares but the only signed agreement says 3,500,000, or when an advisor was "promised 1%" in an email but never granted anything—you have a cap table problem, and cap table problems are among the most common reasons deals slow down or reprice.

The most dangerous cap table defects share a common origin: promises without paper. In the scramble of early-stage life, founders make commitments informally—"you're a co-founder, we'll sort the equity later," "give us six months of work and we'll cut you in," "you can have some options once we incorporate." Each is a contingent claim on the company's equity that may surface, with interest, exactly when you are trying to sell that equity to someone else. The most acute version is the "ghost founder": someone who was around at the beginning—a college roommate who hacked the first prototype, a co-founder who drifted away before anyone signed anything—and who later resurfaces claiming an ownership stake based on that early, informal involvement. The investor's lawyer will ask, in writing, whether anyone has any claim to equity not reflected on the cap table, and you will have to answer truthfully. The cure is discipline: document every early contributor's role and contribution as it happens; if a co-founder leaves, paper the separation and any equity treatment immediately; surface and settle any latent claim before you raise, when it can be resolved for a confirmatory release rather than under the leverage a live financing hands the claimant. Every equity grant goes through the board, gets papered, and lands on the cap table the same week, with no exceptions. "We'll sort it out later" is the most expensive sentence in startup law.

A related issue is the option pool. Investors expect a pool of authorized-but-unissued shares reserved for future employee equity—commonly 10% to 20% of the post-financing capitalization, which is also the typical range carved out of investors' preemptive rights so that ordinary hiring grants do not trigger anti-dilution adjustments. In a priced round, the size and timing of the pool are negotiated, and a subtlety bites unprepared founders: investors typically insist the pool be created or expanded before their money goes in, which means the resulting dilution falls entirely on the existing (founder and early-employee) shareholders rather than being shared with the new investor. This is the "option pool shuffle," and it effectively lowers your real pre-money valuation. Knowing it is coming lets you negotiate the pool size against a defensible hiring plan rather than accepting whatever number the term sheet proposes. We treat the math of the pre-money pool and post-round cap-table mechanics in depth in The Complete Guide to Adding New Investors After Your Seed Round.

A final, easily forgotten point: the cap table must account for convertible instruments. If you sold SAFEs or convertible notes during the seed phase, the shares those instruments will eventually become are real future dilution. A cap table that omits them flatters your ownership and misleads the incoming investor, who will model the conversions and ask why your numbers do not. Model the conversions yourself, on the post-money basis the instruments actually use, so the new investor sees its true ownership before it asks. The mechanics of how SAFEs and notes convert—and the way a stack of post-money SAFEs can quietly consume more of the company than founders expect—are the subject of SAFEs: An Overview of Simple Agreements for Future Equity.

Founder Vesting and the 83(b) Election

If there is one technical topic where founders most often hurt themselves through inaction, it is the interaction of founder stock, vesting, and a small tax form with a brutal deadline. Get it right and it costs nothing. Get it wrong and it can cost a founder a seven-figure tax bill or—worse—their entire stake. This section explains both halves carefully.

Founder Vesting: Why You Want It

Vesting means a person earns their equity over time or upon milestones, rather than owning it all outright on day one. Founder stock is typically issued subject to a repurchase right: the company may buy back the founder's unvested shares (usually at the original, nominal price the founder paid) if the founder leaves before the shares vest. The market-standard schedule is four years with a one-year "cliff"—the first 25% vests only after a full year of service, and the remainder vests monthly (1/48th) thereafter—so a founder who quits after six months walks away with nothing and a founder who stays the full four years owns it all. The repurchase right is generally exercisable for a short window (commonly 90 days) after departure.

Counterintuitively, vesting protects founders from each other. Imagine Acme Robotics has two equal co-founders. Six months in, one of them loses interest and leaves to join a different startup—but, without vesting, that departing founder still owns 50% of Acme. The remaining founder must now build the entire company while a passive ex-partner holds half the equity, contributing nothing and blocking the cap table. That outcome poisons recruiting (why join a company where a no-show owns half?) and is precisely the kind of "dead equity" that makes investors recoil. Vesting prevents it: the departing founder's unvested shares return to the company, restoring the equity to the people actually building. Investors universally expect founders to be on vesting, and frequently require any unvested founder stock to be re-subjected to vesting as a condition of investment. Putting founders on vesting before you raise is both founder-protective and a strong readiness signal—and it pre-empts a term the VC would otherwise impose on its own terms.

A typical founder stock purchase agreement layers in more than vesting. It usually includes a right of first refusal (the company's right to buy back shares before a founder can sell them to an outsider), restrictions on transfer that terminate on an IPO or qualifying merger, a market standoff or lock-up (an agreement not to sell for a period after an IPO—up to 180 days is standard, and up to 360 days in a de-SPAC), and a set of securities-law representations that support the company's exemption from registration when it issues the stock. One practical drafting note that saves real grief later: founders should actually pay for their stock—write a check that the company deposits—rather than leaving the consideration as a vague promise, because a later claim that shares were never paid for can call their valid issuance into question. The agreement also often handles spousal consent in community-property states, where a founder's spouse may have a marital interest in the shares.

The 83(b) Election: The 30-Day Form That Cannot Be Missed

Here is where the tax law intersects, and where the danger lives. When stock is subject to vesting—in tax terms, a "substantial risk of forfeiture"—the default rule under Section 83(a) of the Internal Revenue Code (26 U.S.C. § 83(a)) is that the recipient is taxed as the stock vests, on the difference between the stock's fair market value at vesting and what they paid for it, taxed as ordinary income at rates reaching 37%. For a founder, this default is a disaster waiting to happen. Suppose Acme's stock is worth essentially nothing today but worth $5 per share in three years when a tranche vests; the founder would owe ordinary income tax on that $5 of appreciation per share—each year, as each tranche vests—even though they have not sold a single share or received a dollar of cash. (The classic worked example: 300,000 shares granted at near-zero value that climb to $10 a share would generate $750,000 of ordinary income on the first 25% tranche alone, on stock the founder cannot necessarily sell.)

The escape hatch is an election under Section 83(b) of the Code. By filing it, the founder chooses to be taxed now, at grant, on the spread between the stock's current fair market value and what they paid—rather than later, as it vests (26 U.S.C. § 83(b)). For a founder who buys stock at its fair market value at incorporation, when the company is worth almost nothing, that spread is zero or near zero, so the tax due is zero or near zero. The election "freezes the ordinary income recognition to zero," converts all future appreciation from ordinary income (taxed annually as it vests) into long-term capital gain (taxed only on sale, at a top federal rate of 23.8% including the net investment income tax), and starts both the capital-gains holding period and the QSBS five-year clock running immediately. For a founder buying stock worth almost nothing, filing is close to a no-brainer, and most founders file. The only meaningful downside is that if the founder later forfeits the shares, there is no refund of taxes paid (only a capital loss equal to the amount paid)—which is why the election is genuinely low-risk only when the grant-date value is near zero. For a brand-new company, it is.

Now the deadline, which is the entire point of this section: a Section 83(b) election must be filed with the IRS no later than 30 days after the stock is transferred to the founder (Treas. Reg. § 1.83-2(b), 26 C.F.R. § 1.83-2(b)). This deadline is absolute. It is not 30 business days; it is 30 calendar days. There is no general mechanism to file late, no "reasonable cause" extension, no do-over. A founder who misses the window by a single day loses the election permanently and is locked into the punishing default treatment of Section 83(a). The regulation also dictates the election's content—taxpayer identifying information, a description of the property, the date of transfer and the taxable year, the nature of the restrictions, the fair market value at transfer (counting only nonlapse restrictions), the amount paid, and the amount includible in income (Treas. Reg. § 1.83-2(e))—and the IRS has published sample election language in Revenue Procedure 2012-29 that practitioners use to avoid drafting errors.

The protocol writes itself: file by certified mail, return receipt requested, the moment stock is issued; keep the green card and a copy of the filed election in the corporate records; and have every founder and every early employee who receives restricted stock confirm in writing that they understand the 30-day deadline is their personal responsibility. (Two regulatory updates are worth knowing. The IRS's 2016 final regulations eliminated the old requirement to attach a copy of the election to the recipient's income tax return for property transferred on or after January 1, 2016—but the 30-day filing deadline with the IRS is untouched and remains the thing that matters. And revocation is essentially unavailable: it requires the Commissioner's consent, except where the election was made under a mistake of fact and revocation is requested within 60 days of discovering the mistake.) When an investor's lawyer asks during diligence whether each founder timely filed an 83(b), you want to produce the certified-mail receipts on the spot. A missing or late 83(b) is a classic diligence finding that creates a dangling tax liability and a deeply awkward conversation.

Founder and Contractor IP Assignment: The Diligence Item That Decides Ownership

For most technology startups, the company's value is its intellectual property ("IP")—its code, its inventions, its designs, its brand. An investor is, in substance, buying a claim on that IP. So the single most important thing an investor's lawyer verifies is that the company actually owns the IP it claims to own, with an unbroken chain of title from every human who contributed to it. The IP-and-IT diligence request list is explicit on the point: counsel will demand confirmation that all employees, consultants, and independent contractors who created any material IP signed confidentiality, invention-assignment, or work-for-hire agreements in the company's favor—and will cross-check that no contributor slipped through without one. This is where a shocking number of startups discover, too late, that they do not own their own crown jewels.

Why the Default Rules Do Not Protect You

There is a widespread and dangerous myth among founders that whoever pays for work automatically owns it. That is not how the law works. Under U.S. copyright law, the author of a work is its initial owner, and the "work made for hire" doctrine—which vests ownership in the hiring party—applies automatically only to works created by employees within the scope of their employment. For independent contractors, work-made-for-hire status applies only to a narrow list of statutory categories and only if there is a written agreement saying so. Patent law is even more founder-hostile: absent a written assignment, an inventor owns their own invention, and merely employing or paying someone does not transfer patent rights. The implication is stark. If your brilliant freelance developer in 2023 wrote the core of your product and never signed an assignment, they may own the copyright in that code, and the company merely has an implied, non-exclusive license to use it—nowhere near what an investor is paying for.

The cure is a written assignment of inventions and IP signed by every founder, every employee, and every contractor who touches the product, executed at the start of the relationship and assigning to the company all IP they create in connection with their work. For founders specifically, this typically takes the form of a technology assignment agreement executed at incorporation—which is often the very consideration the founders give for their stock—transferring into the company everything they built before forming it (the prototype, the early code, the domain names, even the social-media handles, which the diligence list specifically flags as something that must belong to the company rather than to a founder personally). For employees and contractors, it is a confidential information and invention assignment agreement (sometimes called a "CIIAA" or "PIIA"). Drafting these so they actually hold up—particularly across states such as California, Washington, and Illinois that statutorily limit how far an employer can reach into an employee's personal inventions—is its own craft, covered in Employee Invention Assignment Agreements: Drafting for Enforceability Across Jurisdictions.

The Diligence Reality and the Gaps That Surface

When an investor's IP diligence runs, the lawyers ask for a signed assignment from every contributor and cross-reference it against your team roster, your contractor invoices, and your code repository's commit history. Several gaps recur with painful regularity. The first is the uncovered early contributor—the cofounder's college roommate who built the first prototype "as a favor," the contractor hired through a freelance marketplace who was paid but never papered, the design agency that produced the logo under a purchase order with no IP terms. The second is the prior-employer problem—a founder who built the product while still employed elsewhere, where the prior employer's own invention-assignment agreement may give it a claim to the founder's work. The third is open-source contamination—code pulled from open-source projects under licenses (especially "copyleft" licenses like the GPL) that may impose obligations on the company's proprietary code, which is why sophisticated diligence segregates open-source usage from proprietary and third-party-commercial code and reviews each license. The fourth, easy to forget, is encumbered inbound licenses: a license whose terms restrict assignment or terminate on a change of control can become a problem the moment you raise or sell. (We address the open-source dimension in Open Source Licensing Landmines in Enterprise Software Development.)

The remedy for all of this is to run your own IP audit before the investor runs theirs. Inventory every person who has ever written code, designed, or invented for the company; confirm a signed assignment exists for each; chase down the missing ones now, while relationships are warm and signatures are cheap. A former contractor asked for a confirmatory assignment as a friendly housekeeping matter usually signs without thinking. The same contractor, contacted in the heat of your Series A because the investor's lawyer flagged the gap, may sense leverage and ask for money—or simply not respond, leaving a cloud over your title at the worst possible moment. Trade secrets, by the way, should be described in a data room only in general terms; the IP diligence list itself recognizes that you protect confidential know-how by describing it generically rather than handing over the recipe.

Employee Equity: ISOs, NSOs, and the 409A Valuation

Once you start hiring, you will grant equity to employees, and doing it correctly is both a recruiting tool and a diligence item. Two concepts dominate: the distinction between incentive and non-qualified stock options, and the 409A valuation that sets your option strike price.

ISOs Versus NSOs

A stock option is the right to buy a share at a fixed "exercise" or "strike" price for a set period (typically five to ten years). Startups grant two flavors. Incentive stock options ("ISOs") receive favorable tax treatment under Section 422 of the Internal Revenue Code but come with strict qualification requirements and may be granted only to employees. Non-qualified stock options ("NSOs," sometimes "NQSOs") lack the special tax treatment but are more flexible and may be granted to non-employees such as advisors and contractors.

The tax difference is meaningful. An employee who exercises an NSO pays ordinary income tax immediately on the "spread"—the difference between the share's fair market value at exercise and the strike price—even though they have not sold anything, and the employer withholds on it. An ISO, by contrast, triggers no regular income tax at grant or at exercise—but the spread at exercise is an adjustment item for the alternative minimum tax ("AMT"), a trap that surprises employees who exercise and hold a high-spread option. If the employee then holds the shares long enough—more than one year after exercise and more than two years after grant—the entire gain is taxed as long-term capital gain; an earlier sale is a "disqualifying disposition" that converts the spread back into ordinary income. To get ISO treatment at all, the option must satisfy Section 422's requirements, which the Code spells out precisely. Among the most important: the option must be granted under a written plan approved by shareholders (within 12 months before or after the board's adoption); the strike price must be at least the fair market value of the stock on the grant date (or 110% of fair market value for an employee who owns more than 10% of the company's voting power); the option must be granted to an employee and generally exercised while employed or within three months of leaving; and—a limit founders frequently overlook—the aggregate fair market value (measured at grant) of ISOs that first become exercisable in any single calendar year cannot exceed $100,000 per employee, with any excess automatically treated as NSOs.

Standing up the equity plan correctly is itself a readiness task investors will check. Listed-company practice—and good private practice—runs the plan through both the board and the shareholders, reserves a fixed share pool that cannot be used for any other purpose once reserved, and documents each grant. Critically, no shares may be issued under the plan before shareholder approval, and while options can be granted in advance of approval if they are not exercisable until then, restricted stock cannot be granted pre-approval at all, because it is deemed issued at grant. These sequencing rules are exactly the kind of formality a diligence lawyer confirms, and getting them wrong creates the issued-without-authorization defect discussed in the housekeeping section.

The 409A Valuation: Why You Cannot Just Pick a Strike Price

Notice that both the ISO rules and ordinary tax hygiene require setting the option strike price at the stock's fair market value on the grant date. For a private company with no public market, who decides what "fair market value" is? You cannot simply invent a low number to make options attractive, because Section 409A of the Internal Revenue Code—the deferred-compensation rules—polices exactly this. If a stock option's exercise price is set below the stock's fair market value on the grant date, the option becomes deferred compensation subject to Section 409A's onerous regime, and the consequences for the employee are severe: income inclusion on the spread as it vests (not when exercised), plus an additional 20% federal penalty tax and interest, on top of ordinary tax—and some states, notably California, pile on a parallel state penalty (26 U.S.C. § 409A). The cruelty of the result is that the employee is "taxed on income the optionee does not actually receive, from shares that may not then or ever be saleable." A sloppy, too-low strike price is not a gift to your employees; it is a tax trap.

The solution is the 409A valuation: an independent appraisal of your common stock's fair market value, used to set option strike prices. The Treasury regulations require a privately held company to determine fair market value "by the reasonable application of a reasonable valuation method" that takes account of all material information (26 C.F.R. § 1.409A-1(b)(5)(iv)(B)). Critically, the regulations offer safe harbors: a valuation made under a qualifying method is presumed reasonable, and the burden shifts to the IRS to overcome that presumption by showing the method was "grossly unreasonable." There are three recognized safe-harbor methods—an independent appraisal, a binding formula valuation, and an "illiquid startup" valuation by a qualified person—but the workhorse for venture-track companies is the independent appraisal, which is presumed reasonable if performed not more than 12 months before the grant and before any intervening material event (26 C.F.R. § 1.409A-1(b)(5)(iv)(B)(2)). In practice, a startup commissions a 409A valuation from a qualified independent firm, sets all option strikes at or above that price, and refreshes the valuation at least every 12 months and after any material event—most obviously a new financing round, which resets the price. Granting options off a stale or absent 409A valuation is a recurring diligence finding; keeping current 409A reports in the data room is a mark of a well-run company.

A Word on QSBS for Founders and Early Employees

We flagged QSBS above; it deserves a second mention because it ties the equity strands together. Under Section 1202, gain on the sale of qualified small business stock held more than five years may be excluded from federal income tax, subject to per-issuer limits, and the benefit depends on the stock being originally issued by a domestic C-corporation meeting the statute's gross-asset and active-business tests. Two readiness implications follow. First, this is another reason to be a C-corporation and to be one early, because the five-year clock runs from issuance. Second, the 83(b) election discussed above starts that clock for restricted founder stock. Founders rarely think about a five-year exit when they incorporate, but those who do—and structure accordingly—often save extraordinary amounts of tax at exit. It is worth a focused conversation with tax counsel at formation, because the rules and dollar caps are technical and have changed over time.

Corporate Housekeeping: The Minute Book Investors Will Actually Read

Glamorous it is not, but corporate housekeeping is where readiness is won or lost in the trenches. The minute book—the organized record of your corporate existence and decisions—is the proof that your company is real, properly authorized, and validly owns and has issued everything on its cap table. When a diligence lawyer cannot reconstruct your company's history from your records, every issuance and every contract becomes a question mark. (Securities-offering diligence typically reaches back three to five years of board, committee, and stockholder minutes for exactly this reason.)

A complete corporate record set includes: the certificate of incorporation (your Delaware charter) and all amendments; the bylaws; the stock ledger (the official register of who owns shares); every stock purchase agreement, option grant, warrant, and convertible instrument; all board consents and minutes authorizing share issuances, option grants, the equity plan, officer appointments, and any material contract or borrowing; all stockholder consents approving the equity plan, charter amendments, and elections of directors; and evidence of good standing and current franchise tax payment in Delaware and any state where the company is qualified to do business.

The principle behind all of this is authorization. Under corporate law, the board of directors must authorize the issuance of stock and the grant of options; an issuance the board never approved is, at best, voidable and, at worst, void. So for every line on the cap table, there must be a board action authorizing it. Startups that grant equity by handshake and "true up the paperwork later" routinely discover, in diligence, that they have issued shares the board never formally approved—a defect ranging from annoying (a cleanup consent) to genuinely serious (a contested issuance). The discipline is unglamorous but simple: nothing of legal significance happens without a board (and, where required, stockholder) approval contemporaneously documented and filed in the minute book. Modern cap-table software helps, but it does not replace the underlying legal authorizations.

Three specific housekeeping items deserve attention because they surprise founders. First, good standing, which is more consequential than it sounds. A corporation that lapses on its annual report or franchise tax falls out of good standing, and the consequences cascade: in many states it cannot prosecute (and sometimes cannot defend) a lawsuit, it risks administrative dissolution, and—most relevant here—a financing simply cannot close, because the deal's legal opinions and closing certificates depend on certified good-standing and charter documents. Courts have even treated a company's failure to obtain a good-standing certificate as evidence of scienter in a securities-fraud case (see SEC v. Infinity Group Co., 212 F.3d 180 (3d Cir. 2000)). And the certificates take time to obtain—many states issue them electronically within hours, but a handful, including California, can take one to two weeks, and expediting fees can run into four figures—so a founder who waits until the closing checklist to discover a lapse has manufactured an avoidable delay. Second, Delaware franchise tax, where the default "authorized shares method" can produce a startlingly large bill—sometimes tens of thousands of dollars—for a startup that authorized many millions of shares, while the alternative "assumed par value capital method" usually produces a far smaller number; you simply have to know to use it. Third, director and officer appointments. Investors check that your officers were actually appointed by the board and your directors actually elected. Loose practices here—"I've always called myself CEO but the board never appointed me"—are easy to fix early and embarrassing to fix late.

Financial Statements and Projections

Investors underwrite a fundraise on a financial picture with two halves: the historical (what has actually happened, captured in financial statements) and the forward-looking (what you project, captured in a financial model). Readiness means both are credible and defensible.

On the historical side, early-stage startups are rarely expected to have audited financial statements (a formal examination by an independent accounting firm); audits are expensive and usually become relevant at later, larger rounds or pre-IPO. But every company should have clean, organized books on a consistent accounting basis (accrual accounting is generally preferred by investors over cash accounting for growth companies because it better matches revenue to the period it was earned), with documentation for material and related-party transactions, and tax filings up to date. A common, avoidable diligence problem is the related-party transaction that was never documented or board-approved—a founder loaning the company money, the company paying a founder's spouse as a contractor, a payment to an entity a director controls. These are not necessarily improper, but they must be disclosed, documented, and, where required, approved by disinterested directors, or they become conflict-of-interest flags. (Diligence lists ask pointedly about loans to and from officers and directors; for public-company-bound startups, the Sarbanes-Oxley prohibition on personal loans to executives looms, but even private companies should treat insider loans as something to be unwound or carefully papered.) The same diligence pass should confirm the tax side is both compliant and optimized: tax filings current in every jurisdiction, any available research-and-development tax credits identified and documented, and—if the company operates across borders—transfer-pricing and other cross-border rules accounted for, since unclaimed credits leave money on the table and unaddressed international exposure becomes a diligence flag.

On the forward-looking side, the financial model is where founders most often undermine their own credibility. The goal is not the most aggressive possible numbers; it is defensible numbers tied to articulated assumptions. A strong model shows the explicit drivers of revenue (so an investor can stress-test them), distinguishes fixed from variable costs, projects cash flow and the resulting "runway" (how many months of cash the company has at its current burn rate), and clearly lays out the intended use of funds—what the money being raised will actually buy and what milestones it will hit. It should also foreground the metrics that matter for your business model, because sophisticated investors read a company through the numbers its sector lives by: a SaaS company by monthly recurring revenue, customer-acquisition cost, and lifetime value; an e-commerce company by gross merchandise value, average order value, and retention; a marketplace by gross transaction value, take rate, and the supply/demand balance that signals liquidity—alongside the universal trio of revenue growth rate, gross margin, and burn-to-runway. Knowing and tracking the right metrics is itself a readiness signal. Building base, upside, and downside scenarios signals that you understand the levers and the risks. The cardinal sin is a hockey-stick projection with no stated assumptions; sophisticated investors discount such models to zero and quietly downgrade their assessment of the founder. There is also a quiet legal dimension: a projection presented as a hard promise, circulated in writing and later contradicted by reality, can become raw material for a misrepresentation claim—so frame projections as projections and assumptions as assumptions.

The Data Room and the Due-Diligence Checklist

We have referenced the data room throughout; now we assemble it. A data room is a secure, organized repository—today, almost always a virtual data room ("VDR"), meaning a permissioned cloud folder—containing the documents an investor needs to verify your company. Building it before you raise, rather than scrambling once a term sheet lands, is perhaps the single highest-leverage readiness task, because it forces you to surface every gap on your own timeline and lets you answer diligence requests in hours rather than weeks.

A well-organized startup data room is structured to mirror how diligence lawyers think, which in turn mirrors the standard M&A diligence request list—because, again, the categories are nearly identical. Typical sections cover: corporate (charter and amendments, bylaws, board and stockholder consents and minutes, good-standing certificates, conversion documents if you converted from an LLC); capitalization (the cap table, stock ledger, all equity issuance documents, the option plan and grant agreements, all 83(b) confirmations, all SAFEs and convertible notes, the most recent 409A valuation); intellectual property (patent and trademark filings, copyright registrations, the full set of founder, employee, and contractor IP assignments, inbound and outbound licenses, open-source usage, domain-name registrations); material contracts (customer agreements, supplier and vendor agreements, leases, and anything with a change-of-control, assignment, exclusivity, or most-favored-nation provision); financials (financial statements, the model, tax returns); employment (org chart, offer letters and employment agreements, the invention-assignment agreements, consulting agreements, benefit plans, and a candid note on worker classification); regulatory and litigation (licenses and permits, privacy policies and data-protection compliance, and a frank disclosure of any threatened or pending disputes); and prior financings (the documents from earlier rounds, including the rights—preemptive, ROFR, co-sale, information, registration—those rounds granted earlier investors, plus the Forms D and blue-sky filings, on which more below).

Running the VDR well is its own discipline, and the M&A playbook applies directly. Assign at least two administrators so the room is never a single-person bottleneck. Before you invite anyone in, delete the provider's training and demo files, verify watermarking, and stage documents in a hidden "preparation" folder where you can review them before they go live. Do not grant access until the investor has signed a non-disclosure agreement, and keep each signed NDA in an admin-only folder—sharing one investor's documents or NDA with another can itself breach a confidentiality obligation. Use granular per-folder permissions (view-only versus download), enable the activity log, and watch it: the log not only tells you who has accessed what, it is a genuine signal of investor interest, since the documents a serious investor lingers on reveal where the deal will actually be negotiated.

Two practices separate an excellent data room from a merely complete one. First, internal consistency: the cap table must reconcile to the equity documents, the financials must reflect the contracts, and the employee list must match the IP assignments. Inconsistency—not the underlying facts—is what erodes investor trust. Second, staged disclosure of the genuinely sensitive: customer names, source code, and trade-secret detail can be held to a later diligence phase, disclosed under a tighter NDA, or redacted, so you are transparent without handing your competitive secrets to an investor who might also back a rival. Build and maintain the data room as a living asset, updated as the company evolves, and you are perpetually a few days—not a few months—from being ready to raise. For the strategic overview of how this fits the whole fundraising arc, return to Navigating the Capital Raising Maze.

Key Documents: Pitch Deck, Term-Sheet Literacy, and NDA Practice

Three documents bracket the readiness-to-raise transition, and a founder should understand each before walking into a meeting.

The pitch deck is your narrative instrument—the 10-to-15-slide story of problem, solution, market, business model, traction, team, and ask. It is a marketing document, not a legal one, but two legal cautions apply. First, do not put forward-looking promises or hard numbers in writing that you cannot defend, because a deck circulated to investors can become evidence; a wildly optimistic projection presented as fact, later contradicted by reality, can support a fraud or misrepresentation claim. Frame projections as projections. Second, the deck is a securities communication: when you are offering securities—even informally—securities law applies, and what you say (and omit) matters. The deck should be consistent with everything in your data room. (How far you can broadcast that deck without tripping the prohibition on "general solicitation" is a Regulation D question addressed at length in Navigating the Capital Raising Maze; the short version is that emailing or posting your pitch to people with whom you have no substantive, pre-existing relationship can itself be a general solicitation that limits which exemption you can claim.)

The term sheet is the short, mostly non-binding document an investor presents to outline the deal's economics and control terms before lawyers draft the long-form agreements. Term-sheet literacy—understanding what each term actually does—is the most valuable single competency a fundraising founder can develop, because the term sheet sets the template that the binding documents (the stock purchase agreement, the investor rights agreement, the voting agreement, the right-of-first-refusal and co-sale agreement, and the amended charter) will faithfully implement. We treat term-sheet negotiation in depth in The Complete Guide to Adding New Investors After Your Seed Round, but the readiness point is this: read and understand your term sheet yourself, with counsel, before you sign. Pay special attention to the liquidation preference (how much investors get back, and in what priority, before common stockholders see anything in a sale—aim for the founder-friendly "1x non-participating" standard); anti-dilution protection; board composition (who controls the board after the round); and protective provisions (the investor veto rights discussed below). A term you do not understand is a term you cannot negotiate.

Anti-dilution deserves a sentence of its own here, because the words sound benign and the variants are not. Anti-dilution protects an investor against a future "down round" at a lower price by adjusting the price at which its preferred stock converts to common. The market-standard, company-fair version is broad-based weighted average, which spreads the adjustment across a large share count and softens it; the punitive version is full ratchet, which resets the investor's conversion price all the way down to the new, lower price regardless of how few shares were issued, transferring a startling amount of value to the investor for no new money. The two are not close in effect, and a founder who cannot tell them apart on a term sheet is negotiating blind. (The mechanics, formulas, and the related "pay-to-play" feature are worked through in the priced-round guide.)

The non-disclosure agreement ("NDA") merits a counterintuitive note. In ordinary commercial dealings, NDAs are routine and prudent. But in venture fundraising, most institutional investors refuse to sign one before hearing a pitch, because they see hundreds of deals, often in overlapping spaces, and cannot accept the litigation risk of being accused of misusing one founder's information to help a competing portfolio company. Demanding an NDA before a first meeting marks a founder as inexperienced and can end the conversation before it starts. The correct readiness posture is to not share genuine trade secrets in early pitches—pitch the vision and the traction, hold back the secret sauce—and reserve NDAs for the later diligence stage, when sensitive technical material actually changes hands and an NDA is appropriate and expected. Getting the content of that later-stage NDA right, especially for technology, is its own discipline, covered in Drafting Enforceable Non-Disclosure Agreements for Technology Transactions.

Governance: Board, Protective Provisions, and the Shift in Control

A venture financing changes how your company is governed, and readiness means understanding the changes before you sign them. Two mechanisms dominate: the board of directors and protective provisions.

The board of directors is the body that, under corporate law, holds ultimate authority over the company—it appoints officers, approves major transactions, and oversees management on behalf of stockholders. Before a venture round, the board is usually just the founders. After a priced round, the investor typically takes one or more board seats, and the negotiation over board composition is among the most consequential in the deal, because it determines who actually controls the company's major decisions. A common, balanced early-stage structure is a board with founder seats, one investor seat, and an independent seat that both sides agree on. Founders should approach this clear-eyed: a board seat is not a courtesy; it is a transfer of control over the matters the board decides. The readiness work is to understand, before signing, exactly how board control will look after this round and after the next one, because each financing tends to add investor seats.

Protective provisions are the second control mechanism, and the one founders most often underestimate. A protective provision is a veto right: a list of corporate actions the company may not take without the approval of the preferred (investor) stockholders, regardless of what the board or common stockholders want. Typical protected actions include selling the company, amending the charter, issuing senior or equal-ranking stock, increasing the option pool, taking on significant debt, and changing the board's size. Reasonable protective provisions are standard and not objectionable—they protect a minority investor from having the rug pulled out from under it. The danger is scope creep: a list so expansive that the company cannot make ordinary operating decisions—hiring, routine spending, signing customer contracts—without investor sign-off, which converts a minority investor into an effective veto over running the business. The readiness posture is to recognize protective provisions for what they are, negotiate them down to genuinely major decisions, and never sign a list you have not read line by line.

Alongside these deal-driven mechanisms, maturing companies adopt the governance hygiene investors like to see: regular, minuted board meetings; clear delineation of which decisions require board approval; basic policies (a code of conduct, a related-party-transaction policy, an insider-information policy as a public listing approaches); and, increasingly, directors-and-officers liability insurance ("D&O insurance"), which protects directors and officers from personal liability for their corporate decisions and which incoming investors and their board nominees almost always require before they will take a seat. None of this needs to be elaborate at the seed stage, but a company that already meets and minutes like a grown-up signals that it will be a competent home for institutional capital.

The Securities-Law Shadow of Your Prior Raises

One readiness item is invisible on a balance sheet and lethal in diligence: the securities-law compliance of the money you already took. Every dollar a startup accepts for stock, a SAFE, or a note is the sale of a "security," and every such sale must either be registered with the SEC under Section 5 of the Securities Act of 1933 or fit within an exemption. Almost every startup relies on the exemptions in Regulation D, and the incoming investor's lawyers will diligence whether your earlier rounds actually qualified—because if they did not, the company carries a latent liability, and the new investor does not want to buy into a rescission problem.

The two exemptions that matter most are Rule 506(b) and Rule 506(c). Rule 506(b) permits an unlimited raise from an unlimited number of accredited investors plus up to 35 non-accredited but sophisticated investors, but it absolutely prohibits "general solicitation"—public advertising of the offering, cold outreach to strangers, posting the deal online. Rule 506(c) permits general solicitation but allows only accredited investors and requires the issuer to take "reasonable steps to verify" each one's accredited status; a checked box on a subscription form is not enough, and a failure to verify "disqualifies the issuer from relying on Rule 506(c)... even if all investors in the offering are in fact" accredited. Both paths require filing a Form D with the SEC within 15 days of the first sale, plus blue-sky notice filings in the states where investors reside. (The full architecture—Rule 504, Regulation Crowdfunding, Regulation A+, the integration framework, bad-actor disqualification, and the ever-present anti-fraud rule of Rule 10b-5—is the subject of Navigating the Capital Raising Maze.)

The readiness implications are concrete. Money taken from friends, family, and angels in earlier rounds may have come from people who were not accredited; if you exceeded the 506(b) non-accredited limit, or solicited generally, or never filed Form D, you have an exposure to flag and, where possible, cure. The diligence cure is documentation: keep, for every prior raise, the subscription agreements with their accredited-investor representations (and verification evidence for any 506(c) round), the Form D filing confirmations, and the blue-sky filings. A startup that can hand the new investor a clean exemption file for each prior round removes one of the quieter ways deals get repriced.

Prior rounds also leave behind contractual rights that can deter a new investor as surely as a compliance gap can. Early shareholders and angels often hold rights of first refusal or first offer, tag-along (co-sale) and drag-along rights, pre-emptive rights to maintain their ownership percentage, and transfer restrictions—each sensible when granted, each a potential impediment to a new investor who wants maximum flexibility and a clean path to future rounds and an exit. Part of getting ready is auditing these legacy rights and, where they conflict with what an incoming investor will demand, negotiating them down before the raise. The levers are familiar: open the conversation early rather than mid-deal; offer something in exchange for a right surrendered (an information right or a board-observer seat can substitute for a heavier governance right); retain part of a right while modifying the rest; and, going forward, write sunset clauses so that certain rights expire automatically on a defined milestone or financing, sparing everyone the renegotiation. The same foresight applies to future liquidity: if an IPO is plausible, underwriters will demand that existing holders sign lock-up agreements, so building a lock-up cooperation obligation—and even a limited power of attorney authorizing the company to execute the lock-up on a holder's behalf—into your shareholder and stock-purchase agreements now avoids chasing signatures later.

Common Legal Landmines That Kill or Reprice Deals

Having walked through the affirmative readiness checklist, it is worth naming the specific findings that most often blow up or reprice venture deals, because pattern recognition is half of prevention. Each is a real, recurring diligence failure.

The broken IP chain. The most lethal: an early contributor—contractor, prior-employer-conflicted founder, or open-source dependency—who leaves the company without clean title to its core technology. An investor cannot fund a company that may not own its product. Fix it by auditing and closing every assignment gap before you raise.

The missing or late 83(b). A founder who never filed the election, or filed it after the 30-day deadline, carries a dangling ordinary-income tax liability and a tainted holding period. There is no clean retroactive fix; the only cure is having filed on time. Confirm and document every founder's timely filing.

The undocumented equity promise. The advisor "promised 1%," the cofounder who left without a signed separation, the employee whose option grant was never board-approved—each is a contingent claim on equity that surfaces in diligence and must be resolved, often by paying the claimant, before the round can close.

The stale or absent 409A. Options granted off no valuation, or off one more than a year old, risk Section 409A penalties for employees and signal sloppy administration. Keep a current independent 409A on file.

The phantom or inconsistent cap table. A cap table that does not reconcile to the underlying documents—or that omits convertible instruments whose conversion will dilute the new investor—forces a painful, trust-eroding reconciliation exactly when momentum matters.

Worker misclassification. Treating people who function as employees as "contractors" to save on taxes and benefits creates back-tax, penalty, and benefits exposure that diligence will surface, and it can also undermine the IP chain, because the default IP rules differ for employees and contractors.

Securities-law exposure from prior raises. As the previous section explains, money taken without a valid exemption is a latent liability—non-accredited investors may have rescission rights, and improper general solicitation can taint the offering. Investors diligence prior financings precisely to flush this out.

A lapse in good standing. A missed Delaware franchise-tax payment or annual report drops the company out of good standing and can stall a closing that depends on certified good-standing documents—an avoidable, self-inflicted delay.

Undisclosed litigation, liens, or material-contract problems. A pending lawsuit, a tax lien, or a customer contract that terminates on a change of control can each reprice or kill a deal if it surprises the investor. The rule is iron: disclose proactively, with context and a mitigation plan, rather than letting the investor's lawyer discover it. A disclosed problem is a negotiation; a discovered, hidden problem is a credibility crisis.

Worked Example: Acme Robotics Gets Diligence-Ready

Let us put it together. Acme Robotics, Inc. is a two-founder company building warehouse robots with proprietary control software. The founders, Dev and Priya, started as a Delaware LLC two years ago, hired two freelance developers in year one, sold two SAFEs to angels last year, and now plan to raise a $3 million seed round in six months. They engage counsel early to get diligence-ready. Here is what the process surfaces and fixes.

Entity. Counsel confirms the LLC must become a Delaware C-corporation before institutional investors will engage, and recommends a statutory conversion. A contract review turns up one customer agreement with a change-of-control clause; a brief call and a consent letter clear it. The conversion is timed so the founders' QSBS five-year clock begins as early as possible.

Founder equity and 83(b). On conversion, Dev and Priya each receive restricted common stock subject to four-year vesting with a one-year cliff—protecting each from the other and pre-empting an investor-imposed term—and each writes a real check for the par value. Counsel walks them through the 83(b) election, and both file by certified mail within 30 days of issuance, using the Revenue Procedure 2012-29 sample language; the green cards go straight into the minute book. Because the stock is worth almost nothing at conversion, the tax due is effectively zero, and all future appreciation is now positioned for long-term capital-gains (and potentially QSBS) treatment.

IP chain. The IP audit finds the landmine: one of the year-one freelancers was paid but never signed an assignment, and that freelancer wrote a meaningful chunk of the control software. Because the freelancer was an independent contractor with no work-made-for-hire agreement, Acme may not own that code. Counsel reaches out now—while the relationship is friendly—and the freelancer signs a confirmatory assignment for a nominal sum, restoring clean title months before any investor would have flagged it. Both founders sign a technology assignment transferring their pre-incorporation work, the domain name, and the company's social handles into the company, and a confidential-information-and-invention-assignment agreement is put in place for all future hires.

Employee equity and 409A. Acme adopts a board- and stockholder-approved equity incentive plan with a 15% option pool sized to a defensible 18-month hiring plan, and commissions an independent 409A valuation so the first employee option grants carry a defensible strike price and qualify as ISOs within the $100,000 annual limit.

Prior raises. Counsel reviews the two SAFEs. Both angels were accredited and signed subscription agreements with accredited-investor representations, a Form D was filed within 15 days of the first sale, and the relevant blue-sky notices went out. The exemption file is clean—and now it lives in the data room.

Housekeeping and data room. Counsel reconstructs and organizes the minute book—charter, bylaws, board and stockholder consents authorizing every issuance and the equity plan, the stock ledger, and a Delaware good-standing certificate with franchise tax paid using the assumed-par-value method (which slashes the bill). The cap table is rebuilt to reconcile exactly to the underlying documents, including the two SAFEs, whose conversion is now modeled on a post-money basis so the incoming seed investor can see its true dilution. Everything lands in an organized virtual data room, with two administrators, watermarking on, and customer names held back to a later diligence phase under NDA.

When the seed investor's lawyer opens that data room six months later, the diligence runs in days, not months. There are no surprises, no repricing levers, no awkward "we'll get back to you." The round closes on schedule at the negotiated valuation—not because Acme got lucky, but because Acme got ready. That is the entire thesis of this article in a single sentence.

Key Takeaways

Preparation, not pitching, is the part of fundraising most within your control, and it is where rounds are quietly won and lost. Become a Delaware C-corporation early, because it is the entity venture money is structured to flow into and the gateway to clean equity compensation and QSBS. Keep a cap table that reconciles, line by line, to signed and board-approved documents—including your convertibles—and never let an equity promise outrun its paperwork. Put founders on vesting and file every 83(b) election within the absolute 30-day deadline of Treasury Regulation Section 1.83-2(b). Secure an unbroken IP chain of title from every founder, employee, and contractor, because investors are, in substance, buying that IP. Grant employee equity off a current 409A valuation to stay inside the Section 409A safe harbor and clear of the 20% penalty, and document everything in a minute book and a living data room that mirrors the standard diligence checklist. Keep a clean Regulation D exemption file for every prior raise, stay in good standing, read your term sheet yourself, understand protective provisions and anti-dilution before you sign them, and disclose every problem proactively rather than letting diligence discover it. Do all of this before you need to, when fixes are cheap, and you will walk into your raise as a clean, fundable asset rather than a renovation project.

Frequently Asked Questions

Do I really need to convert from an LLC to a C-corporation before raising venture money? For institutional venture capital, almost always yes—many funds are contractually prohibited from investing in pass-through entities, and equity compensation, preferred stock, and QSBS all work cleanly only in a C-corporation. The exceptions tend to be small or specialized raises; for a standard venture path, plan on a Delaware C-corp. Discuss the conversion method with tax counsel, since the wrong route can trigger tax or reset your QSBS clock.

What happens if a founder misses the 30-day 83(b) deadline? The election is lost permanently, and the founder is stuck with the default rule under Section 83(a): ordinary-income tax as the stock vests, on the appreciation, even with no sale and no cash received. There is no general late-filing relief, which is why the protocol is to file by certified mail the moment stock is issued and keep the receipt. Treat the 30-day deadline (Treas. Reg. § 1.83-2(b)) as immovable.

Why won't venture investors sign my NDA before a pitch? Institutional investors see many deals in overlapping spaces and cannot accept the risk of being accused of misusing one founder's information to help a competitor. Asking for an NDA before a first pitch signals inexperience. The right move is to not disclose true trade secrets early, and reserve a properly drafted NDA for the diligence stage, when sensitive technical material actually changes hands.

What is a 409A valuation and how often do I need one? It is an independent appraisal of your common stock's fair market value, used to set option strike prices so that options are not treated as below-market deferred compensation subject to a 20% penalty under Section 409A. A qualifying independent appraisal creates a rebuttable presumption of reasonableness, shifting the burden to the IRS. Refresh it at least every 12 months and after any material event, such as a new financing round.

Who actually owns code written by a contractor we paid? Not necessarily the company. Absent a signed IP assignment (and, for copyright, a written work-made-for-hire agreement where the doctrine even applies), an independent contractor may retain ownership of what they create, leaving the company with only an implied license. This is one of the most common and most dangerous diligence findings; audit and close every assignment gap before you raise.

What is the difference between an ISO and an NSO, and why does the $100,000 limit matter? An incentive stock option (ISO) can qualify for capital-gains treatment and avoids ordinary income at exercise (though the spread is an AMT item), but only employees can receive ISOs and they must satisfy Section 422—including that no more than $100,000 of ISOs (measured by grant-date value) first become exercisable for any employee in a single year, with the excess automatically treated as a non-qualified option (NSO). NSOs are more flexible (advisors and contractors can hold them) but are taxed as ordinary income on the spread at exercise.

Could our earlier friends-and-family round create a problem when we raise institutional money? Yes. Those sales were sales of securities and needed a valid exemption—usually Rule 506(b), which allows accredited investors plus up to 35 sophisticated non-accredited investors but forbids general solicitation, with a Form D filed within 15 days of the first sale. If you took money from too many non-accredited investors, advertised the round publicly, or never filed, you may carry a rescission or enforcement exposure that diligence will surface. Keep a clean exemption file for every prior raise. See Navigating the Capital Raising Maze.

How early should I start getting diligence-ready? As early as possible—ideally from formation, and certainly many months before you intend to raise. Nearly every readiness fix is cheap and easy when you have time and warm relationships, and expensive or impossible when a term sheet is already on the table and the clock is running.

Related Articles

This article is provided by mclaw.io for general informational purposes only and does not constitute legal or tax advice, nor does it create an attorney-client relationship. Securities, tax, and corporate law are fact-specific and change over time; the citations and rules described here may not reflect the most current authority or apply to your situation. Before forming an entity, granting equity, filing tax elections, or raising capital, consult qualified corporate, securities, and tax counsel licensed in your jurisdiction.